Placebo-Controlled Single Dose Study to Evaluate Safety and Pharmacokinetics of SXC-2023 in Healthy Volunteers
Clinical trial NCT03301298 · COMPLETED
Trial details
- NCT number
- NCT03301298
- Sponsor
- Promentis Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-09-11
- Primary completion
- 2018-02-13
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.